683 Capital Management »

Revolution Medicines shares owned by 683 Capital Management

Quarter-by-quarter ownership of Revolution Medicines (RVMD) shares owned by 683 Capital Management from 13F filings

Historical chart of 683 Capital Management investment in Revolution Medicines

Tip: Access up to 7 years of quarterly data

All positions including Revolution Medicines held by 683 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revolution Medicines by 683 Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.9M 50k 97.25

More positions owned by 683 Capital Management

Palantir Technologies Cl A Put Option (PLTR)
Eli Lilly & Co. (LLY)
NVIDIA Corporation Put Option (NVDA)
Capital One Financial (COF)
Alnylam Pharmaceuticals (ALNY)
Carvana Cl A (CVNA)
Madrigal Pharmaceuticals Put Option (MDGL)
Tesla Motors Put Option (TSLA)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Protagonist Therapeutics (PTGX)
Praxis Precision Medicines I Com New Put Option (PRAX)
Wave Life Sciences SHS (WVE)
Becton, Dickinson and (BDX)
Kaspi Kz Jsc Sponsored Ads (KSPI)
Anaptysbio Inc Common (ANAB)

View all positions for 683 Capital Management

Top funds holding Revolution Medicines

Vanguard Group
Farallon Capital Management
BlackRock
Henderson Group
Baker Bros. Advisors
FMR
Vanguard Capital Management
Nextech Invest
Vanguard Portfolio Management
Wellington Management Company
Paradigm Biocapital Advisors
Bellevue Group
UBS Group
State Street Corporation
Geode Capital Management

View all funds holding Revolution Medicines